Additional file 2 (.xlsx): Table S1 . List of AS exons in the infected T-cells Additional file 3 (.xlsx): Table S2 . List of AS genes in the enriched canonical pathways Additional file 4 (.xlsx): Table S3 . List of AS genes in the enriched GO terms RNA-Seq data from HIV-infected and noninfected T-cells from the SRA database in NCBI (SRP094482) XH+ : HIV-infected XH-: HIV-exposed, non-infected
Control groups

Case group
Step 1
rMATs -Identification of alternative spliced mRNAs and calculation of expression ratios
Step 3
• FastQC and Trimmomatic -Quality control and trimming
• TopHat -Mapping reads to human reference genome (hg19)
Step 2
• Functional gene set enrichment analysis of genes differentially spliced in HIV-infected T-cells • Classify into immune related genes, T-cell function related genes, and transmembrane genes
• Functional impact of gene with differentially spliced in HIV-infected T-cells
Step 4
Figure S1. Overview of AS analysis in HIV-infected and non-infected human primary resting CD4 + T-cells. We obtained RNA-Seq data for infected and non-infected cells from SRA (reference number SRR5071107-SRR5071122). There are four different treatment groups, and group contained four different cells . We then performed general quality control on the reads, aligned them to the hg19 human reference genome, and selected junction reads to identify alternatively spliced exons. Next, we identified mRNAs with differential alternatively splicing between the case group and each control. The percent spliced in (PSI) ratio indicates the level of differential exon expression. We adjusted q value < 0.05, and used PSI > 0.01 as the cutoff for differential splicing. Finally, we performed functional gene set enrichment analysis and classified genes with differential spliced exons in HIV infected T-cells according to their functional roles. Figure S3 . 21 GO terms enriched in 427 HIV-associated AS genes. GO Biological Process (BP) and Molecular Function (MF) terms were considered significant at a FDR corrected q-value < 0.05 (red line).
Figure S4.
A plot for providing evidence to select quiescent cells. Ki67 is a proliferation marker, which is not expressed in quiescent cells but is expressed in dividing cells. The graph below shows the ki67 level of cells at Day19 (red line), which was negative, indicative of lack of cell division. 207,940,357 -207,940,540 207,941,123 -207,941,168 (45bp) 207,943,665 -207,943,707 207,956,636 -207,956 
